Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used

International Journal of Neuropsychopharmacology

Volumn 15, Issue 9, 2012, Pages 1265-1274

  Le Foll, Bernard ^a,b   Chakraborty Chatterjee, Munmun ^a   Lev Ran, Shaul ^a   Barnes, Chanel ^c   Pushparaj, Abhiram ^a   Gamaleddin, Islam ^a   Yan, Yijin ^a   Khaled, Maram ^a   Goldberg, Steven R ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cue induced reinstatement; drug discrimination; nicotine; progressive ratio schedule; varenicline

Indexed keywords

NICOTINE; VARENICLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ANIMALS; BENZAZEPINES; CONDITIONING, OPERANT; CUES; DATA INTERPRETATION, STATISTICAL; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; FEEDING BEHAVIOR; MALE; MOTIVATION; NICOTINE; QUINOXALINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TOBACCO USE DISORDER;

EID: 84871526073     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001398     Document Type: Article

References (21)

1. Cahill K, Stead LF, Lancaster T (2007). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews. Issue 1. Art. No. CD006103.
2. Corrigall WA, Coen KM (1989). Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berlin) 99, 473-478.
3. Corrigall WA, Coen KM, Zhang J, Adamson KL (2001). GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology (Berlin) 158, 190-197.
4. Department of Health and Human Services (1990). The Health Benefits of Smoking Cessation : a Report of the Surgeon General (DHHS publication no. 90-8416). Washington, DC: Government Printing Office.
5. Donny EC, Caggiula AR, Mielke MM, Booth S, et al. (1999). Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berlin) 147, 135-142.
6. Forget B, Pushparaj A, Le Foll B (2010a). Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biological Psychiatry 68, 265-271.
7. Forget B, Wertheim C, Mascia P, Pushparaj A, et al. (2010b). Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology 35, 1751-1760.
8. Franklin T, Wang Z, Suh JJ, Hazan R, et al. (2011). Effects of varenicline on smoking cue-triggered neural and craving responses. Archives of General Psychiatry 68, 516-526.
9. George O, Lloyd A, Carroll FI, Damaj MI, et al. (2011). Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berlin) 213, 715-722.
10. Justinova Z, Ferré S, Barnes C, Wertheim CE, et al. (2009). Effects of chronic caffeine exposure on the involvement of adenosine a1 and a2A receptors in the discriminative-stimulus effects of nicotine, methamphetamine and cocaine in rats. Psychopharmacology (Berlin) 203, 355-367.
11. Le Foll B, George TP (2007). Treatment of tobacco dependence: integrating recent progress into practice. Canadian Medical Association Journal 177, 1373-1380.
12. Le Foll B, Sokoloff P, Stark H, Goldberg SR (2005). Dopamine D3 ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30, 720-730.
13. Le Foll B, Wertheim CE, Goldberg SR (2008). Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neuroscience Letters 443, 236-240.
14. Lerman C, Lesage MG, Perkins KA, O'Malley SS, et al. (2007). Translational research in medication development for nicotine dependence. Nature Reviews Drug Discovery 6, 746-762.
15. LeSage MG, Shelley D, Ross JT, Carroll FI, et al. (2009). Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacology, Biochemistry, and Behavior 91, 461-467.
16. O'Connor EC, Parker D, Rollema H, Mead AN (2010). The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berlin) 208, 365-376.
17. Roberts DS (1992). Self-administration of stimulants and serotonergic systems. NIDA Research Monograph 119, 136-140.
18. Rollema H, Chambers LK, Coe JW, Glowa J, et al. (2007). Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52, 985-994.
19. Rollema H, Hajos M, Seymour PA, Kozak R, et al. (2009). Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochemical Pharmacology 78, 813-824.
20. Tobacco Advisory Group RCP (2000). Nicotine addiction in Britain : a report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians of London.
21. Wouda JA, Riga D, De Vries W, Stegeman M, et al. (2011). Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. Psychopharmacology (Berlin) 216, 267-277.